Search Results 1621-1630 of 18037 for Lupus
This study will test a study drug called cemiplimab to see if it can help treat early-stage cutaneous squamous cell carcinoma (CSCC), a type of skin cancer.
This phase Ib/II clinical trial studies the side effects and best dose of venetoclax and how well it works when given together with vincristine liposomal in ...
This tool could alert a patient's primary care team of a probable IPF diagnosis based on comorbidities and risk scores. The tool should prompt earlier referral ...
Experts in biomedical engineering, neurosurgery, neurology, orthopedics and more guide research in Mayo Clinic's Department of Neurologic Surgery.
Mayo Clinic researcher Louis J. Faust, Ph.D., leverages wearable health sensors to enhance healthcare delivery models and improve patient outcomes.
Blocking PARP may help keep tumor cells from repairing their damaged DNA, causing them to die. PARP inhibitors are a type of targeted therapy. Adding ...
Progress in the diagnosis and treatment of this kidney cancer have greatly improved the outlook for children with the condition.
The purpose of this study is to see if the combination of rituximab and ibrutinib can help people with marginal zone lymphoma who have not received treatment in ...
The primary aim of the study is to compare safety and effectiveness of two methods of endoscopic resection of large colorectal polyps: cold snare EMR (without ...
The Acute Leukemia/Myelodysplasia Group at Mayo Clinic evaluates and treats patients with other leukemias and disorders of bone marrow function, including:.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.